Click here for more information about Algenuity
Click here for more information about LiqofluxPhenometrics Buy 3 Get 1 Free
Visit cricatalyst.com!Evodos Separation Technology Check out more of The Buzz spacer

Dr. Craig Behnke joins Lumen Bioscience as SVP

July 16, 2018
AlgaeIndustryMagazine.com

Dr. Craig Behnke has joined Lumen Bioscience as Senior Vice President, Production and Development.

Lumen Bioscience, a Seattle company developing novel biologics on its proprietary spirulina expression platform, has announced that Dr. Craig Behnke has joined its executive team as Senior Vice President, Production and Development.

Dr. Behnke will assume leadership of Lumen’s existing production and development teams. He joins as Lumen launches its first product, RioBlue™, a high-purity protein extract used as a blue colorant by the food and cosmetics industries. Dr. Behnke previously served as Vice President of Research and Development at Sapphire Energy in San Diego, a pioneer in the industrial-scale cultivation of photosynthetic microbes.

“We are pleased to welcome Dr. Behnke to Lumen’s senior leadership team,” said Brian Finrow, Lumen’s CEO and co-founder. “Craig’s experience makes him the perfect leader to scale commercial production beyond our current facility in Seattle. His scientific background and history of scaling up biological systems at Sapphire will be invaluable as we continue to expand our capacity.”

Used first as a nutritional supplement for its naturally high protein, vitamin and antioxidant content, US spirulina extract sales soared after 2014 when the FDA approved it for use as a natural food colorant. Today it remains the only approved natural blue food pigment in the US, and is used mainly as a natural alternative to FD&C Blue #1, an artificial food colorant that is synthesized from petroleum.

“I am thrilled to be joining such a talented group of scientists, engineers, and quality professionals,” Dr. Behnke said. “This team has built a robust, integrated, cGMP-compliant production system to produce the highest possible quality product. They’ve laid a great foundation as we look to scale production to meet global demand over the next 24-36 months. Over the course of my career I have had the good fortune to participate in some remarkable achievements in bio-process yield improvement, and I’m excited to help unlock the enormous commercial potential of this fascinating new platform.” Dr. Behnke holds a Ph.D. in Biochemistry from the University of Washington and an M.S. in Biochemistry from Kansas State.

In addition to its core colorants business, Lumen has also won research funding to use its new platform to develop ultra-low-cost biologic drugs and vaccines, all of which rely upon the same integrated, FDA cGMP production platform. In May, the National Institutes of Health awarded Lumen a grant to continue developing its oral malaria vaccine, and last month Lumen announced additional research funding from the United States Department of Agriculture and the Bill & Melinda Gates Foundation for other vaccine and antibody research programs.

More Buzz…

Copyright ©2010-2019 AlgaeIndustryMagazine.com. All rights reserved. Permission required to reprint this article in its entirety. Must include copyright statement and live hyperlinks. Contact editorial@algaeindustrymagazine.com. A.I.M. accepts unsolicited manuscripts for consideration, and takes no responsibility for the validity of claims made in submitted editorial.

twittertopbarlinks_eventstopbarlinks_requesttopbarlinks_archives

From The A.I.M. Archives

— Refresh Page for More Choices
Hayley Dunning writes from the Imperial College of London that a new discovery has changed our understanding of the basic mechanism of photosynthesis and should rewrite t...
Sophie Kevany writes in Decanter.com that a group of vineyards in France’s Bordeaux and Cognac regions are exploring whether algae can be used to prevent the fungal infec...
Israeli-based Algatechnologies, Ltd. (Algatech), is teaming up with the Italian R&D company, Sphera Encapsulation S.r.l (Sphera), to develop innovative functional ingredi...
E.A. Crunden writes in thinkprogress.org that Florida’s first gubernatorial debate was dominated by environmental and climate issues, with an emphasis on the state’s alga...
Jason Huffman writes in UndercurrentNews.com that the Kampachi Company, a mariculture business focused on expanding the environmentally sound production of sashimi-grade ...
Environmental Technology magazine notes that the difficulty in predicting how algae blooms will develop lies in their variform nature. With a multitude of different bloom...
Paris-based Solabia Group (“Solabia”) has acquired Algatech Ltd., a global leader in the development, cultivation and commercialization of ingredients delivered from micr...
Steve Fountain writes in fortstocktonpioneer.com that, amid the 800-page law that last month set the country’s farm policy through 2023, is the expansion of federal suppo...
Cécile Barbière writes for Euractive.fr (translated by Rob Kirby) that, in large greenhouses formerly home to the tomatoes and cucumbers of the market gardening Groupe Ol...
At the Technical University of Denmark (DTU), Science Nordic.com reports, researchers are investigating bioluminescent algae, to determine whether bioluminescent organism...
Researchers at Los Alamos National Laboratory and partner institutions have provided the first published report of algae using raw plants as a carbon energy source. The r...
Julianna Photopoulos writes in Horizon EU Research and Innovation magazine that UK start-up Skipping Rocks Lab aims to use natural materials extracted from plants and sea...